Melyssa M Godfrey,
Clinical Research Coord I
Department:
MD-RHEUMATOLOGY
Business Phone:
(352) 265-8901
Business Email:
melyssa.godfrey@medicine.ufl.edu
Publications
Academic Articles
2023
Efficiency of pain inhibition and facilitation of fibromyalgia patients is not different from healthy controls: Relevance of sensitivity-adjusted test stimuli.
British journal of pain.
17(2):182-194
[DOI] 10.1177/20494637221138318.
[PMID] 37057258.
2023
Fibromyalgia is associated with hypersensitivity but not with abnormal pain modulation: evidence from QST trials and spinal fMRI.
Frontiers in pain research (Lausanne, Switzerland).
4
[DOI] 10.3389/fpain.2023.1284103.
[PMID] 38116188.
2023
Nociplastic pain: the wolf in sheep’s clothing. Comment on the article by Sunzini et al.
Arthritis & rheumatology (Hoboken, N.J.).
[DOI] 10.1002/art.42685.
[PMID] 37651266.
2022
Hand size estimates of fibromyalgia patients are associated with clinical and experimental pain.
PloS one.
17(7)
[DOI] 10.1371/journal.pone.0270701.
[PMID] 35877689.
2021
Fibromyalgia Patients Are Not Only Hypersensitive to Painful Stimuli But Also to Acoustic Stimuli.
The journal of pain.
22(8):914-925
[DOI] 10.1016/j.jpain.2021.02.009.
[PMID] 33636370.
2021
Spinal cord neural activity of patients with fibromyalgia and healthy controls during temporal summation of pain: an fMRI study.
Journal of neurophysiology.
126(3):946-956
[DOI] 10.1152/jn.00276.2021.
[PMID] 34406893.
2020
Usefulness of Ramp & Hold Procedures for Testing of Pain Facilitation in Human Participants: Comparisons With Temporal Summation of Second Pain.
The journal of pain.
21(3-4):390-398
[DOI] 10.1016/j.jpain.2019.08.004.
[PMID] 31425887.
Grants
Jul 2023
ACTIVE
A randomized, parallel-group, double-blind, placebo-controlled,
multicenter Phase III trial to evaluate efficacy
and safety of secukinumab administered subcutaneously
versus placebo, in combination with a glucocorticoid taper
regimen, in patients with polymyalgia rheumatica (PMR)
Role: Other
Funding: NOVARTIS PHARMACEUTICALS CORP
Nov 2020
– Apr 2023
Biomarker evaluation for the differential diagnosis and monitoring of fibromyalgia compared to autoimmune rheumatic diseases, other pain syndromes, and normal subjects
Role: Other
Funding: EXAGEN
Contact Details
Phones:
- Business:
- (352) 265-8901
Emails:
- Business:
- melyssa.godfrey@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100221
GAINESVILLE FL 32610 - Business Street:
-
BOX 100221
1600 SW ARCHER RD
GAINESVILLE FL 32610